Bisacodyl Limits Chikungunya Virus Replication


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
21 06 2022
Historique:
pubmed: 3 6 2022
medline: 24 6 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

Identifying novel antivirals requires significant time and resource investment, and the continuous threat of viruses to human health necessitates commitment to antiviral identification and development. Developing antivirals requires years of research and validation, and recent outbreaks have highlighted the need for preparedness in counteracting pandemics. One way to facilitate development is to repurpose molecules already used clinically. By screening such compounds, we can accelerate antiviral development. Here, we screened compounds from the National Institutes of Health's Developmental Therapeutic Program for activity against chikungunya virus, an alphavirus that is responsible for a significant outbreak in the Americas in 2013. Using this library, we identified several compounds with known antiviral activity, as well as several novel antivirals. Given its favorable

Identifiants

pubmed: 35652314
doi: 10.1128/aac.00292-22
pmc: PMC9211418
doi:

Substances chimiques

Antiviral Agents 0
Bisacodyl 10X0709Y6I

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0029222

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM138199
Pays : United States

Références

Lancet Infect Dis. 2017 Apr;17(4):e107-e117
pubmed: 28159534
Neurogastroenterol Motil. 2018 Jul;30(7):e13311
pubmed: 29441646
Drug Discov Today. 2022 Jul;27(7):1954-1960
pubmed: 35192924
Respir Res. 2021 Nov 27;22(1):304
pubmed: 34838020
Cell Host Microbe. 2016 Aug 10;20(2):167-77
pubmed: 27427208
PLoS Pathog. 2014 Jan;10(1):e1003877
pubmed: 24453971
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G887-95
pubmed: 21868635
Aliment Pharmacol Ther. 2009 Nov 1;30(9):930-6
pubmed: 19678812
Dig Dis Sci. 1980 Aug;25(8):602-8
pubmed: 6249558
J Virol. 2017 Oct 13;91(21):
pubmed: 28814523
Carbohydr Polym. 2015 Dec 10;134:82-91
pubmed: 26428103
N Engl J Med. 2014 Sep 4;371(10):887-9
pubmed: 25184860
Science. 2021 Jul 30;373(6554):541-547
pubmed: 34326236
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Biomed Res. 2016;37(1):13-20
pubmed: 26912136
Curr Res Pharmacol Drug Discov. 2022;3:100072
pubmed: 34901833
Curr Mol Med. 2022;22(10):929-940
pubmed: 33602083
Curr Res Pharmacol Drug Discov. 2021;2:100058
pubmed: 34870156
Future Microbiol. 2021 Nov;16:1341-1370
pubmed: 34755538
Antiviral Res. 2018 Oct;158:226-237
pubmed: 30149038
Antiviral Res. 2018 Sep;157:57-67
pubmed: 29981794
J Anal Toxicol. 1998 Jul-Aug;22(4):274-8
pubmed: 9681329
Cell Host Microbe. 2016 Aug 10;20(2):259-70
pubmed: 27476412
Eur J Pharmacol. 2021 Dec 5;912:174569
pubmed: 34653378
Ann Hepatol. 2011 Oct-Dec;10(4):458-68
pubmed: 21911886
Curr Opin Virol. 2014 Oct;8:10-5
pubmed: 24846716
Virology. 2019 Sep;535:227-231
pubmed: 31325837
Insect Biochem Mol Biol. 2005 Oct;35(10):1162-70
pubmed: 16102421
Biochim Biophys Acta Mol Cell Res. 2017 Jun;1864(6):1018-1027
pubmed: 28109792
Int J Mol Sci. 2016 Jul 20;17(7):
pubmed: 27447626
J Clin Invest. 2017 Mar 1;127(3):737-749
pubmed: 28248203
ACS Infect Dis. 2021 Aug 13;7(8):2337-2351
pubmed: 34129317
Drugs. 2018 Jul;78(10):995-1012
pubmed: 29946962
Neurogastroenterol Motil. 2021 Oct;33(10):e14123
pubmed: 33751780
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32284379
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137799
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16038-43
pubmed: 21896755
Clin Gastroenterol Hepatol. 2011 Jul;9(7):577-83
pubmed: 21440672
Bioorg Med Chem. 2021 Sep 15;46:116356
pubmed: 34416512
JAMA. 2016 Jan 12;315(2):185-91
pubmed: 26757467
New Microbiol. 2013 Jul;36(3):211-27
pubmed: 23912863
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Curr Top Med Chem. 2017;17(12):1320-1330
pubmed: 28017149
Curr Med Chem. 2021;28(15):2887-2942
pubmed: 32787752

Auteurs

Natalie J LoMascolo (NJ)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
Infectious Diseases and Immunology Research Institute, Maywood, Illinois, USA.

Yazmin E Cruz-Pulido (YE)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

Bryan C Mounce (BC)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
Infectious Diseases and Immunology Research Institute, Maywood, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH